China Online Medical Device Sales Quality Management Rules (Announcement No. 46 of 2025)

1. Key takeaways

The Quality Management Specification for Online Sales of Medical Devices (Announcement No. 46 of 2025) was published on 28 April 2025 and takes effect on 1 October 2025; it runs to four chapters and 50 articles.

• Responsibility splits into two types of party — online sales operator and e-commerce platform operator — whose duty lists differ and cannot share one document.
• Online sale does not lower access requirements: Class I filing and Class II and III registration (Article 13 of the Regulation) apply equally online.
• Instructions and label information shown on a page are governed by the Provisions on Instructions and Labels (former Order No. 6): text in Chinese (Article 9), no unauthorised alteration of registered content (Article 16).
• The operator carries first responsibility for product and information compliance; the platform carries responsibility for order within it. Separate duty sets, not joint substitutes.
• After commencement, having rules is not enough: the online system must connect to the offline one and face inspection under the same logic.
• The window between publication and commencement was short, so remediation should be ordered by risk (practical estimate).

2. Legal basis

Administrative regulation. Medical Device Supervision and Administration Regulation (State Council Order No. 739), promulgated 9 February 2021, effective 1 June 2021. Article 6: classification by risk. Article 13: Class I filed, Class II and III registered, with lifecycle liability. Article 20, paragraph 1: the five duties of the holder.

Departmental rules. Measures for the Administration of Medical Device Registration and Filing (SAMR Order No. 47), promulgated 26 August 2021, effective 1 October 2021. Article 8: Class I filed with the municipal authority, Class II with the provincial drug administration, Class III with NMPA. Article 15: quality system. Article 27: instructions and label requirements.

Provisions on the Instructions and Labels of Medical Devices (former State Food and Drug Administration Order No. 6), promulgated 30 July 2014, effective 1 October 2014.

• Article 4: content scientific, true, complete and accurate, consistent with registration or filing. Article 7: minimum sales unit carries instructions.
• Article 9: Chinese text, other languages permitted but Chinese prevailing. Article 10: fourteen items. Article 13: eleven label items. Article 14: eight prohibitions, including absolute wording, cure rates and comparative claims.
• Article 16: registered instruction content may not be altered without authorisation.

Business rules. Measures for the Supervision and Administration of Medical Device Business (SAMR Order No. 54), promulgated 10 March 2022, effective 1 May 2022.

Normative documents. Quality Management Specification for Online Sales of Medical Devices (Announcement No. 46 of 2025), 28 April 2025, effective 1 October 2025, four chapters and 50 articles. Measures for the Supervision and Administration of Online Sales of Medical Devices: the document number and effective date are outside the verification scope of this paper and must be checked separately.

Practical estimate. The article-level content of Announcement No. 46, the filing or notification procedure for operators and the detail of platform review duties are not held here as verified text. The allocation below follows the structure of the Specification and is a practical estimate; build the system against the text in force and current provincial requirements.

3. Expert insights

The words quality management in the title mark where supervision has moved. The earlier framework, represented by the Measures for the Supervision of Online Sales, centred on access and conduct: who may sell, where, what must be reported. Announcement No. 46 puts quality management in the title, shifting the centre to process: how information is reviewed, how orders and delivery are recorded, how complaints and adverse events flow back.

Online business could once sit with the e-commerce department and appear nowhere in the manual; it must now fall inside the system documents.

Two parties, two checklists.

The duties differ in nature: the operator’s concerns compliance of specific products, the platform’s concerns order within the platform. One combined procedure leaves both sides incomplete, with the product review flow on the platform side and the onboarding check on the operator side.

Page content is regulated information, not marketing copy.

The last row carries the highest risk: rewriting the intended use or deleting warnings is unauthorised alteration under Article 16, a different order of seriousness from ordinary information irregularity.

Four chapters and 50 articles translate into an executable document list. The scale shows an operational instrument that maps article by article onto internal rules, so build the revision as a mapping table.

The mapping buys speed at inspection; without it, each question sends staff through several files.

Online and offline systems must connect at three interfaces. Online sale is not a separate channel but an outlet of the business quality system.

The third interface is the most neglected: online channels reach end users directly and are a major signal source, so complaints closed by customer service and never entered in the ledger leave a structural blind spot in the Article 20, paragraph 1, item (3) monitoring duty.

4. Practical recommendations

• Write separate documents for the two parties, each matching its own chapters.
• Audit every page once against the instruction and label rules: Chinese wording (Article 9), fourteen items (Article 10), eight prohibitions (Article 14), no unauthorised change (Article 16).
• Lock the page instruction version to the registration file and update it on every certificate change, keeping a version log.
• Build the mapping table from all 50 articles to internal rules and record forms so inspection can locate evidence quickly.
• Feed online complaints into the vigilance ledger within a set time limit (practical estimate), with no separate closure inside customer service.
• Unify product master data under the certificate number as key, not two data sets.
• Order remediation by risk: page content before record forms, and traceability and vigilance rebuilds started early because they take longest (practical estimate).

5. Verification checklist

• □ Separate documents exist for the two types of party
• □ Articles of Announcement No. 46 (effective 1 October 2025) mapped to documents and forms
• □ Page instructions in Chinese, with Chinese prevailing (Article 9)
• □ Displayed instructions carry fourteen items and labels eleven (Articles 10, 13)
• □ No absolute wording, cure rates or comparisons — the eight prohibitions (Article 14)
• □ Page content consistent with the registered instruction (Articles 16, 4)
• □ Certificate data and intended use updated when the certificate changes
• □ Online orders traceable to batch and distribution flow
• □ Quality complaints enter the vigilance ledger and adverse event process
• □ Recall plan covers online take-down and notification
• □ Platform operator verifies and records seller qualifications

How GRZAN can help. GRZAN provides medical device and IVD registration, quality system, authorised representative and local testing support for the Chinese market. Our team manages adverse event monitoring and recall filings with NMPA, maintains UDI compliance, and supports post-market vigilance obligations. Business enquiries: info@grzanglobal.com